In this issue, Leukemia presents the first contributions to the above-mentioned debate. The commentaries address facts and questions pertaining to the topic of RT-PCR controls discussed by Dr Kidd and Dr Lion in their opening comments published in earlier issues of Leukemia and reprinted in the following pages. The controversial viewpoints put forward by V Kidd and T Lion provided the stimulus for this debate, which is being pursued at a time when the use of RT-PCR techniques is becoming widely disseminated, making it increasingly important to ensure that the laboratories involved provide reliable results. In this context, the use of adequate controls is certainly one of the critical issues.
We hope that the debate on this provocative topic will lead to a consensus enabling us to issue generally acceptable guidelines. However, a consensus will not be forced, and it is understood that guidelines need to be revised.
NMB, Editor ␤-actin for validation of RT-PCR tests is still not uncommon. It may not be possible to assess the integrity of a particular RNA species of interest with absolute certainty, but it is necesExamining the presence of amplifiable RNA is an essential sary to select control genes and primer combinations which control step in reverse transcriptase-polymerase chain reacwill reveal the presence of amplifiable RNA and which will tion (RT-PCR) experiments. Amplification of ␤-actin gene not yield PCR products of similar size from cDNA and gensequences was a very commonly used approach to determinomic DNA templates. Different genes have been used as coning the availability of sufficiently intact RNA (cDNA) in the trols for the validity of RT-PCR results. [4] [5] [6] [7] [8] For example, amplisamples analyzed. It has been shown, however, that the fication of sequences from the ABL proto-oncogene has human genome contains processed ␤-actin pseudogenes, 1 provided a convenient control system for RT-PCR assays in which can result in the amplification of fragments from genhematopoietic cells displaying the BCR-ABL rearrangement:
9 omic DNA displaying similar size to those generated from a when using a set of primers which will amplify a fragment cDNA template. Since RNA preparations frequently contain across a 0.6 kb intron between exons 2 and 3, products of traces of genomic DNA, amplification of a sequence from the easily distinguishable size will be generated from genomic ␤-actin gene can yield a PCR product of the expected size DNA and cDNA template sequences. Hence, in addition to even in the absence of intact RNA (Figure 1 ; panel D). Theredemonstrating the presence of amplifiable RNA, this system fore, ␤-actin may not be regarded as a suitable control for RNA integrity in RT-PCR analysis.
2 Additionally, ␤-actin is a of a ␤-actin control may therefore lead to wrong interpretation PCR products from three human RNA specimens extracted from perof PCR assays if the gene investigated is expressed at a markipheral blood leukocytes as described. 10 cDNA from the three speciedly lower level. 3 These considerations have not been mens (lanes 1-3) was amplified using primers derived from the human ␤-actin (panel A), ABL (panel B), and beta 2-microglobulin (␤ 2 MG) (panel C) gene sequences. As shown in panel B, amplification of an ABL gene sequence with primers spanning a 0.6 kb intron revealed the presence of contaminating genomic DNA in specimens 1 and 3 ( * ) which escaped detection by the ␤-actin and ␤ 2 MG primers used. Bands representing specific PCR products from the respective RNA/cDNA templates are marked by arrows. (Panels D-F) PCR from genomic DNA samples using the same sets of ␤-actin (panel D), ABL (panel E), and ␤2 MG (panel F) primers. Amplification of ␤-actin DNA in two different specimens (panel D, lanes 1 and 2) revealed products of identical size (arrow) to the RNA/cDNA-specific products displayed in panel A apparently due to the presence of ␤-actin pseudogenes in the human genome. Additional weak bands ( * ) could have resulted from the presence of two short introns of approximately 0.1 kb, one spanned by the primers employed, the other located within the sequence of the sense primer which shows homology at the 3′ end to the following intron sequence. In panel E, lane 1 shows the expected ABL gene-derived DNA fragment (arrow) identical to that displayed in panel B (lanes 1 and 3); lane 2 depicts the ABL amplification product from RNA/cDNA derived from the same cell sample. The bands displayed in panel F (lanes 1 and 2) (arrow) reflect the presence of a 0.6 kb intron within the DNA segment amplified. In contrast to PCR analysis with the ABL primers, amplification with the ␤2MG primers did not reveal a genomic DNA product in RT-PCR experiments in which the RNA/cDNA template was contaminated with genomic DNA (panel C, samples 1 and 3). This can be attributed to the fact that the 0. before an experimental study is initiated.
1 like to address some of the issues raised by Dr Kidd. The fact that I do not believe that the method of RNA purification should for years ␤-actin controls were the most widely used approach to greatly influence our selection of RT-PCR controls. Even if techthe assessment of RNA integrity certainly raises questions about niques were available which virtually eliminate the possibility of the validity of earlier RT-PCR studies which relied on the ampli-DNA contamination in RNA preparations, it might not be advisfication of sequences from this gene to determine the presence able to use control primers permitting amplification of similarof intact RNA. The existence of processed ␤-actin pseudogenes sized products from gDNA and cDNA. For example, traces of in the human genome does not per se invalidate earlier experigDNA in samples containing partially or largely degraded RNA ments using ␤-actin as a control, but critical results, particularly could result in the misinterpretation of RT-PCR assays. Regardless if they were negative, might warrant judicious reassessment.
of how small the likelihood of such a scenario might be, would More importantly, however, we have to be concerned with it obviate the need for controls allowing specific assessment of the choice of appropriate controls in current and future RT-PCR amplifiable RNA in the samples analyzed? studies. If, as pointed out by Dr Kidd, there are commercial RTIn many instances, the presence of contaminating gDNA in PCR kits providing ␤-actin control primers, they need to be carean RNA preparation has no major adverse effect on the results fully tested for their ability to amplify products of similar size of RT-PCR analysis. Therefore, it may not be essential to demfrom genomic DNA and cDNA templates. We have shown that a onstrate whether an RNA template is free of gDNA by amplifyset of ␤-actin primers facilitating amplification across two introns ing a target sequence with a set of DNA-specific primers. If yielded a main product of identical size, regardless whether the detection of gDNA in RNA samples is of interest, it might be more reasonable for many applications to design primers present in the target gene. Such primers will work both for cDNA and gDNA templates, but will yield products of differregarded as the minimum requirement for RT-PCR controls? Should the primers used either span a large intron sequence ent size depending on the type of template. In most experiments, however, the main requirement for RT-PCR controls is to prevent amplification of gDNA or should they encompass one or more short introns to facilitate amplification of distinct not proving the presence or absence of contaminating DNA, but assessing RNA integrity in the sample investigated. In a products from cDNA and gDNA templates? It is not the aim of this round table discussion to defend number of laboratories, the quality of total RNA preparations is determined by evaluating ribosomal RNA bands upon certain standpoints. Rather, the knowledge and the experience of different investigators should help us establish a consensus electrophoresis in (non-) denaturing agarose gels. The stability of various RNA species may be different, which makes conon this important topic, and ultimately, enable us to provide recommendations for appropriate controls in future RT-PCR trols for integrity of a specific target RNA of interest very difficult. In diagnostic assays for the detection of tumor cell-spestudies. cific transcripts from rearranged genes, some investigators use control primers for mRNA of one or both genes involved. The primers are designed to amplify PCR products from a region References located near the fusion point.
1-3 This strategy permits detection of transcripts from the rearranged gene(s), but also of nor- ␤-actin pseudogenes present in the genome. Moreover this well-taken, and reinforce the need to reach a certain level of gene, as for most house-keeping genes, is expressed at a much consensus, due to the dramatic increase in the use of reversehigher level than most of the fusion mRNA currently detecttranscription polymerase chain reaction (RT-PCR) within diagable in hematological malignancies. This issue is even more nostic procedures. Although the steps to be considered for the relevant for the amplification of fusion mRNA (such as proper control of a RT-PCR reaction are several, the issue of PML/RAR-␣ or MLL/AF4) whose RT-PCR is approximately one the availability of sufficiently intact RNA (cDNA) in the log less sensitive than the RT-PCR applied to different chimsamples analyzed does represent the most relevant one. Most eric genes generated by other chromosomal abnormalities, of the methods currently available for the preparation of such as the BCR/ABL. It is still an open question as to whether mRNA from tissue specimens give intact mRNAs. In our a common reference gene can be used as standard control for experience, we found that the RNA extraction obtained by RT-PCR reactions, or whether the amplification of one of the ultracentrifuge through a CsCl cushion gives the most reliable two genes involved in the translocation would be preferable. results (especially in terms of mRNA stability and DNA As a practical guideline it is more feasible to use the amplificontamination) and is the most appropriate for residual discation of the same gene for all the RT-PCR reactions to be ease study since it is necessary to use larger samples to achiperformed routinely. In that context, the primers should be eve maximum sensitivity. The Chomczynski method has the selected to facilitate amplification of distinct products from advantage that an ultracentrifuge is not required and usually cDNA and genomic DNA. Within the BIOMED concerted is the method of choice when a larger number of samples action on the standardization of the molecular detection of need to be processed. We control the quality of total RNA chromosomal translocations in leukemia, we have agreed on preparations by evaluating ribosomal bands using polyacrylthe use of amplification of the ABL proto-oncogene and to amide or agarose gel electrophoresis, even in the routine diagperform either PCR and RT-PCR with the same ABL primers, nostic analysis samples (more that 600 per year) that we to check for DNA contamination as well as for RNA integrity. receive for the molecular identification of chromosomal trans- to enable results to be effectively standardized in quantitative
Commentary from LAJ Janssen and CR Bartram contained enough ␤-actin template to produce a signal, even if a mock cDNA synthesis was performed without the addition of reverse transcriptase. 4 Institute for Human Genetics, University of Heidelberg, In our laboratory RT-PCR techniques are not only used in Germany research projects, but also in a diagnostic setting. In the latter type of analysis we learned that the quality of the test depends In his invitation to a round-table discussion, Dr Lion raised on the use of an appropriate control. We believe that a good several crucial questions with regard to the use of appropriate control should fulfil the following criteria: (1) The expression controls for RT-PCR analysis. 1 Although an earlier discussion level of the control gene should correspond to the expression has led to the conclusion that the amplification of ␤-actin level of the gene product under investigation. The expression sequences is not a reliable test for the quality of the cDNA level of ␤-actin will most often be too high to be useful. 3 In template, 2,3 many investigators still use and publish results of CML and ALL patients, the expression level of the normal ABL studies based on ␤-actin controls. The possible misinterpretgene is comparable to the level of the BCR-ABL fusion gene ation of data is due to the presence of a large number of proand therefore can be regarded as an appropriate contol in this cessed ␤-actin retropseudogenes in the human genome. to the relevance of these guidelines and apply them in future 5 Lion T. Control genes in reverse transcriptase chain reaction tests. We therefore appreciate the opportunity to reach conassays. Leukemia 1996; 10: 1527-1528, and this issue.
sensus criteria through this round-table discussion.
Commentary from E Macintyre and J Gabert on behalf of trols were included to avoid false results. Firstly, the specificity the diagnostic laboratories of the LALA94 Adult Acute of the PCR products analyzed on agarose gels was systematiLeukemia Trial (with the participation of C Bilhou-Nabera, cally confirmed either by a shifted PCR on the same cDNA, JM Cayuela, N Frehoy, D Bories, C Bastard, P Martiat, F using an internal and an external primer (one laboratory) or Davi, M Dupont, S Raynaud and S Hayette by Southern blotting and hybridization with an internal oligoprobe labelled with a radioisotope ( 32 P) (three laboratories) or with biotin (nine laboratories). Nested PCR techniques were Laboratoire de Biologie Cellulaire, Centre Anti-Cancéreux, avoided because of the high risk of PCR contamination. 8 SecMarseille, France ondly, two positive controls were performed: (1) control for RNA integrity and quality of the RT reaction by amplification First, we are grateful to Leukemia for initiating such a debate.
of an ubiquitously expressed gene, either the porphobilinogen Controls for RT-PCR are not only important for scientific decarboxylase (PBGD) gene or the Abelson (ABL) gene; (2) reasons but also because therapeutic decisions are increascontrol for amplification of the specific fusion transcript: in ingly based on such molecular data. We believe that this each experiment pure RNA and a 10 −1 dilution (RNA in RNA) round table will help to improve quality controls (QC) and for all positive cell lines (TOM-1 for m-BCR, RS 4-11 for MLLdefine the necessary guidelines. Dr V Kidd and Dr T Lion AF4 and IARC 318 for E2A-PBX1) were used as positive conopened the debate about the appropriate control for checking trols except for K562 which is known to express high levels RNA integrity and the quality of the reverse transcription of M-BCR mRNA and was therefore used at a 10 −2 dilution. step.
1,2 We would like to share our experience of QC for These cell lines were shared by all laboratories. Thirdly, RT-PCR in the context of a therapeutic trial.
because of the excellent sensitivity of PCR assays, the guideIn the French multicenter LALA94 trial for adult acute lymlines previously described were very strictly followed. 9 Negaphoblastic leukemias (ALL), patient stratification for the tive controls were included to detect possible cross-contamisecond randomization after induction therapy is based on nation, ie amplification was performed with all reagents identification of poor prognosis factors defined in adult ALL. 3, 4 except for nucleic acids in each experiment. Nevertheless, this Among these, the t(9;22), t(1;19) and t(4;11) translocations are control does not allow the detection of cross-contamination clearly independent poor prognostic factors. 5 A group of 13 by PCR products in RNA samples. One way to minimize this laboratories work as a network to identify the four correspondproblem is to use uracyl-N-glycosylase prior to the PCR reacing fusion transcripts: BCR-ABL (m-BCR and M-BCR), MLLtion. 10 The incorporation of dUTP instead of dTTP allows spe-AF4 and E2A-PBX1, in order to provide the data before the cific degradation of possible PCR product contaminants before second randomization (day 35). 6 In this commentary, we the amplification step. However, one has to be aware that this describe the QC which we consider necessary during the RTprocedure does not eliminate the need to strictly follow the PCR analyses of diagnostic samples with avoidance of false basic guidelines. positive results as a priority. In addition to QC, retrospective Apart from the classical guidelines, it was decided to adopt inter-laboratory controls on cells or cell lysates are being additional controls whenever a positive RT-PCR result for a performed.
fusion transcript is obtained. Firstly, a mock RT-PCR is perfor-308 adult ALL (aged between 15 and 55 years) from 34 med from the same RNA, omitting the reverse transcriptase centers were included during a period of 28 months. Diagnosduring the RT reaction, the so-called 'RT negative control'. If tic blood and/or bone marrow samples, collected in heparin any contaminating PCR products were present in the RNA or EDTA tubes, were sent to one of the 13 reference laborasample it would be amplified, thus allowing detection of tories by express mail either as fresh samples within 24 h or cross-contamination. Secondly, if a positive RT-PCR result after Ficoll separation as cells in DMSO on dry ice. RT-PCR cannot be confirmed by another technique such as classical analyses were performed as previously described.
7 Briefly, the cytogenetics, fluorescent in situ hybridization (FISH) or Southstandard protocol included an M-MLV reverse transciption ern blotting, the analysis is repeated (extraction, RT and PCR) reaction with random hexamers and 1 g of RNA. Common from a second aliquot of the same sample. If discrepant results primers were used for the specific PCR reactions performed are obtained from the two samples, material (preferably with 10 to 20% of the cDNA. 6 The following precautions and positive and negative concellular) is sent to another laboratory within the group. An Finally, an inter-laboratory QC program on coded samples The karyotype was normal based on 20 mitoses examined.
QC for RT-PCR should be retained in order to avoid falseCommentary from C Mannhalter and G Mitterbauer increasingly for numerous applications in the very near future. Thus, it is essential that these kits include adequate controls Department of Laboratory Medicine, Division of Molecular for RNA integrity as well as for detection of contamination of Biology, Medical School of the University of Vienna, Austria RNA with genomic DNA. As Dr Lion pointed out, 1 one should never rely on PCR con-PCR and RT-PCR are used increasingly in diagnostic applitrol primers which allow amplification of similar-sized procations. This emphasizes the need for appropriate controls for ducts from gDNA and cDNA, as is the case with certain ␤-the PCR reaction and for assessment of intact and amplifiactin primer pairs, 2 not even when using very good RNA isoable RNA.
lation methods. Treatment of RNA with RNAse-free DNAse, One can expect that commercial RT-PCR kits will be used as recommended by Dr Kidd, 3 has to be applied with caution. interest.
Commentary from P Páldi-Haris and J Fö ldi
National Institute of Haematology and Immunology, Department of Molecular Genetics, Budapest, Hungary
Storage of samples at different stages of processing prior to RT-PCR analysis might affect the integrity of mRNA transcripts. We have therefore investigated the effect of storage on the stability of different types of mRNA. In our laboratory, patients with chronic myeloid leukaemia are routinely analysed for the presence of the chimaeric bcrabl mRNA, and amplification of the normal abl gene message serves as a control for mRNA integrity in the samples tested.
1
For preparation of total RNA, we use the method described under different storage conditions. Cells were dissolved in highly purified GT (Sigma G9277) and were divided into multiple aliquots. One aliquot was processed and analysed eto chimeric mRNAs. Our preliminary results suggest that the immediately, the others were placed at −70°C for different degradation rate of the pml-rara message is similar to that of periods of time prior to analysis by RT-PCR (Figure 1) . In a bcr-abl. The aml-eto message showed less pronounced, but different series of experiments, the samples were redissolved detectable degradation. We conclude therefore that instability in GT after the first precipitation step, and were either of chimaeric mRNAs during storage might be a common deposited at −70°C during the second precipitation step or phenomenon. were immediately submitted to RT-PCR analysis. After hybridHence, in addition to the issues discussed by T Lion 3,4 and isation of the PCR products to a 32 P-labelled abl2-abl3 exon V Kidd, 5 differences in stability between the target gene and probe, the ratio between the chimaeric bcr-abl message and the control gene need to be considered in RT-PCR assays, the normal abl message was determined by phosphoimage particularly if storage of samples is involved. analysis. Evaluation of the bcr-abl/abl ratios in samples processed as indicated above revealed preferential degradation of the fusion mRNA during storage. The half-life of the bcrReferences abl mRNA relative to the normal abl transcripts was 28 days in samples stored in GT, and 20 days in samples stored during Scientists who wish to participate in the debate are invited to send their commentaries to either chairman with a copy to the Editor-in-Chief.
